Literature DB >> 1497365

Histologic features of paraneoplastic pemphigus.

T D Horn1, G J Anhalt.   

Abstract

BACKGROUND: We describe the histopathologic features of paraneoplastic pemphigus, a recently described autoimmune mucocutaneous disease associated with neoplasia. Complete evaluation for paraneoplastic pemphigus requires identification of the characteristic mucocutaneous eruption, tissue specimens for routine histologic and direct immunofluorescence evaluation, and identification of circulating autoantibodies with a unique specificity. Immunoprecipitation from keratinocytes reveals a characteristic complex of four proteins with the circulating antibodies. Various neoplasms have been identified in patients with paraneoplastic pemphigus. OBSERVATIONS: We reviewed 16 skin and oral mucous membrane biopsy specimens from six patients with paraneoplastic pemphigus confirmed by fulfillment of all criteria. Major features include epidermal acantholysis, suprabasal cleft formation, dyskeratotic keratinocytes, vacuolar change of the basilar epidermis, and epidermal exocytosis of inflammatory cells. Seven (44%) of 16 specimens displayed a unique combination of suprabasal acantholysis and dyskeratotic keratinocytes throughout the epidermis. These histologic findings correspond to those of the characteristic clinical lesions that are described as having features of pemphigus and erythema multiforme.
CONCLUSIONS: Paraneoplastic pemphigus represents a unique clinical, histologic, and immunologic disease characterized by autoantibody production to desmoplakin I and desmoplakin II, bullous pemphigoid antigen, and, possibly, other antigens in the desmosomal complex. Recognition of the histologic features should prompt immunopathologic confirmation and evaluation for an occult neoplasm.

Entities:  

Mesh:

Year:  1992        PMID: 1497365

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  8 in total

Review 1.  Management of autoimmune skin disorders in the elderly.

Authors:  Wei Jing Loo; Nigel P Burrows
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 2.  Autoantibodies against adhesion molecules and structures in blistering skin diseases.

Authors:  J R Stanley
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

Review 3.  Paraneoplastic pemphigus: a short review.

Authors:  Marta Wieczorek; Annette Czernik
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-09-23

Review 4.  Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Authors:  Chun-Bing Chen; Ming-Ying Wu; Chau Yee Ng; Chun-Wei Lu; Jennifer Wu; Pei-Han Kao; Chan-Keng Yang; Meng-Ting Peng; Chen-Yang Huang; Wen-Cheng Chang; Rosaline Chung-Yee Hui; Chih-Hsun Yang; Shun-Fa Yang; Wen-Hung Chung; Shih-Chi Su
Journal:  Cancer Manag Res       Date:  2018-05-17       Impact factor: 3.989

Review 5.  Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm.

Authors:  Hanan Rashid; Aniek Lamberts; Gilles F H Diercks; Hendri H Pas; Joost M Meijer; Maria C Bolling; Barbara Horváth
Journal:  Am J Clin Dermatol       Date:  2019-12       Impact factor: 7.403

6.  Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview.

Authors:  Celina Wakisaka Maruta; Denise Miyamoto; Valeria Aoki; Ricardo Gomes Ribeiro de Carvalho; Breno Medeiros Cunha; Claudia Giuli Santi
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

Review 7.  Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review.

Authors:  Heng L Tham; Keith E Linder; Thierry Olivry
Journal:  BMC Vet Res       Date:  2020-11-23       Impact factor: 2.741

Review 8.  Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus.

Authors:  Adriana Maria Porro; Livia de Vasconcelos Nasser Caetano; Laura de Sena Nogueira Maehara; Milvia Maria dos Santos Enokihara
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.